Analyst IMS Investment Management Services’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,557
| Closed | -$583K | – | 141 |
|
|
2024
Q2 | $583K | Hold |
13,557
| – | – | 0.02% | 94 |
|
|
2024
Q1 | $574K | Hold |
13,557
| – | – | 0.03% | 84 |
|
|
2023
Q4 | $566K | Hold |
13,557
| – | – | 0.03% | 76 |
|
|
2023
Q3 | $513K | Hold |
13,557
| – | – | 0.03% | 77 |
|
|
2023
Q2 | $514K | Hold |
13,557
| – | – | 0.03% | 71 |
|
|
2023
Q1 | $329K | Sell |
13,557
-4,100
| -23% | -$120K | 0.03% | 79 |
|
|
2022
Q4 | $520K | Hold |
17,657
| – | – | 0.04% | 77 |
|
|
2022
Q3 | $507K | Hold |
17,657
| – | – | 0.05% | 76 |
|
|
2022
Q2 | $638K | Hold |
17,657
| – | – | 0.06% | 73 |
|
|
2022
Q1 | $764K | Sell |
17,657
-5,098
| -22% | -$238K | 0.07% | 76 |
|
|
2021
Q4 | $1.14M | Hold |
22,755
| – | – | 0.11% | 69 |
|
|
2021
Q3 | $1.45M | Hold |
22,755
| – | – | 0.18% | 58 |
|
|
2021
Q2 | $1.64M | Hold |
22,755
| – | – | 0.2% | 52 |
|
|
2021
Q1 | $1.68M | Hold |
22,755
| – | – | 0.22% | 49 |
|
|
2020
Q4 | $1.67M | Hold |
22,755
| – | – | 0.28% | 40 |
|
|
2020
Q3 | $1.25M | Hold |
22,755
| – | – | 0.25% | 43 |
|
|
2020
Q2 | $1.51M | Hold |
22,755
| – | – | 0.35% | 33 |
|
|
2020
Q1 | $1.39M | Sell |
22,755
-5,683
| -20% | -$421K | 0.45% | 30 |
|
|
2019
Q4 | $2.5M | Hold |
28,438
| – | – | 0.68% | 23 |
|
|
2019
Q3 | $2.14M | Hold |
28,438
| – | – | 0.64% | 25 |
|
|
2019
Q2 | $2.43M | Hold |
28,438
| – | – | 0.72% | 22 |
|
|
2019
Q1 | $3.07M | Hold |
28,438
| – | – | 0.95% | 18 |
|
|
2018
Q4 | $2.41M | Sell |
28,438
-3,000
| -10% | -$289K | 0.38% | 30 |
|
|
2018
Q3 | $3.08M | Hold |
31,438
| – | – | 0.49% | 19 |
|
|
2018
Q2 | $3.62M | Hold |
31,438
| – | – | 1.11% | 17 |
|
|
2018
Q1 | $3.1M | Hold |
31,438
| – | – | 0.98% | 19 |
|
|
2017
Q4 | $3.29M | Hold |
31,438
| – | – | 1.01% | 23 |
|
|
2017
Q3 | $3.52M | Hold |
31,438
| – | – | 1.16% | 22 |
|
|
2017
Q2 | $3.52M | Hold |
31,438
| – | – | 1.25% | 22 |
|
|
2017
Q1 | $3.69M | Hold |
31,438
| – | – | 1.44% | 19 |
|
|
2016
Q4 | $3.31M | Hold |
31,438
| – | – | 1.45% | 17 |
|
|
2016
Q3 | $3.47M | Hold |
31,438
| – | – | 1.47% | 18 |
|
|
2016
Q2 | $4.58M | Sell |
31,438
-25
| -0.1% | -$3.54K | 1.93% | 16 |
|
|
2016
Q1 | $4.51M | Sell |
31,463
-1,500
| -5% | -$213K | 1.94% | 15 |
|
|
2015
Q4 | $5.09M | Hold |
32,963
| – | – | 2.13% | 14 |
|
|
2015
Q3 | $4.71M | Sell |
32,963
-115
| -0.3% | -$16.1K | 1.99% | 15 |
|
|
2015
Q2 | $4.75M | Buy |
+33,078
| New | +$4.72M | 1.85% | 16 |
|
|
2015
Q1 | – | Sell |
-36,078
| Closed | -$5.35M | – | 105 |
|
|
2014
Q4 | $5.35M | Buy |
+36,078
| New | +$5.3M | 2.06% | 15 |
|
Other funds holding TARO
Analyst IMS Investment Management Services's TARO Position: Q3 2024 in Review
Analyst IMS Investment Management Services sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2024, closing a stake of 13,557 shares — an estimated $583K sold.
Analyst IMS Investment Management Services first reported a position in TARO in Q4 2014 and held it in 38 quarters. The position peaked at $5.35M in Q4 2014. 6 funds tracked by Wall St. Rank hold TARO as of Q3 2024.
- Analyst IMS Investment Management Services reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2024 after selling out during the quarter.
- Analyst IMS Investment Management Services sold 13,557 Taro Pharmaceutical Industries Ltd. shares in Q3 2024, an estimated $583K.
- Analyst IMS Investment Management Services first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2014 and held it in 38 quarters.
- Analyst IMS Investment Management Services's Taro Pharmaceutical Industries Ltd. position peaked at $5.35M in Q4 2014.
- 6 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2024.
Based on Analyst IMS Investment Management Services's 13F filing for Q3 2024, filed 12 Nov 2024.